Accuracy of Pretransplant Imaging Diagnostic for Hepatocellular Carcinoma: A Retrospective German Multicenter Study

Table 1

Patient and tumor characteristics.

Recipient age (years);	57.9 ± 8.4
mean ± standard deviation
Recipient gender (male/female [%])	78% / 22%
Diagnosis [%]
(i) Viral hepatitis	52%
(ii) Alcoholic cirrhosis	27%
(iii) Autoimmune hepatitis/PBC/PSC	3%
(iv) Unclear cirrhosis	6%
(v) Other cause	5%
(vi) HCC in non-cirrhotic liver	5%
Bridging therapy [%]
(i) Resection	21%
(ii) TACE	75%
(iii) RFA	18%
(iv) Ethanol injection	9%
(v) Radiation	6%
(vi) Cryotherapy	<1%
>100% due to patients with multiple bridging therapies
Tumor staging [%]
Primary tumor
(i) T1	39%
(ii) T2	45%
(iii) T3	16%
(iv) T4	1%
Regional lymph nodes
(i) N0	98%
(ii) N1	2%
Distant metastasis
(i) M0	99%
(ii) M1	1%
Vascular invasion
(i) V0	79%
(ii) V1	21%
Invasion lymphatic vessels
(i) L0	94%
(ii) L1	6%
Resection boundaries [%]
(i) R0	99%
(ii) R1	1%
Grading [%]
(i) G1	17%
(ii) G2	73%
(iii) G3	11%